On enzyme-based anticancer molecular dietary manipulations

Andrea Sapone1, Donatella Canistro, Simone Melega

  • 1Molecular Toxicology Unit, Department of Pharmacology, Alma-Mater Studiorum, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy. andrea.sapone@unibo.it

Insights

Focusing on single nutrients from fruits and vegetables to prevent cancer is not viable. A healthy diet, emphasizing whole foods and dietary patterns, is key to reducing cancer risk and promoting health.

Area of Science:

  • Nutritional Science
  • Biochemistry
  • Cancer Research

Background:

  • Epidemiological and experimental data suggest fruits and vegetables prevent cancer and heart disease.
  • Dietary approaches have simplified to using single bioactive components or functional foods to manipulate xenobiotic metabolism.
  • This manipulation aims to enhance detoxification or inhibit bioactivation of mutagens/carcinogens.

Purpose of the Study:

  • To evaluate the viability of manipulating physiological catalysts through isolated nutrient administration.
  • To challenge the simplified approach of using single bioactive components for disease prevention.
  • To propose an alternative strategy for cancer risk reduction and public health policy.

Main Methods:

  • Review of existing epidemiological and experimental evidence.
  • Analysis of the biological outcomes of enzyme modulators.
  • Theoretical evaluation of long-term administration of isolated nutrients.

Main Results:

  • The manipulation of physiological catalysts via isolated nutrients is not a viable strategy.
  • Single bioactive components can have unpredictable and paradoxical biological effects.
  • The concept of easily manipulating enzyme activity with isolated compounds is flawed.

Conclusions:

  • Consumption of healthy diets, rather than isolated compounds, is most likely to reduce mutagenesis and cancer risk.
  • Research and dietary recommendations should shift focus from single molecules to dietary patterns.
  • Dietary patterns represent a more effective public health strategy for disease prevention.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...